Highview Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.62M Buy
+11,128
New +$1.54M 0.46% 58
2023
Q3
– Sell
-9,569
Closed -$1.1M – 107
2023
Q2
$1.1M Sell
9,569
-100
-1% -$11.4K 0.59% 51
2023
Q1
$1.03M Buy
9,669
+192
+2% +$20.7K 0.59% 51
2022
Q4
$1.05M Buy
9,477
+312
+3% +$31.9K 0.64% 47
2022
Q3
$789K Buy
9,165
+2,015
+28% +$180K 0.59% 47
2022
Q2
$652K Sell
7,150
-423
-6% -$37.5K 0.5% 54
2022
Q1
$621K Buy
7,573
+3,564
+89% +$281K 0.4% 71
2021
Q4
$307K Buy
+4,009
New +$319K 0.2% 89

Other funds holding MRK

Highview Capital Management's MRK Position: Q3 2026 in Review

Highview Capital Management opened a new position in Merck (MRK) in Q3 2026: 11,128 shares worth $1.62M. The stake represents 0.46% of the portfolio and ranks #58 among its holdings. This is a return to the name: Highview Capital Management previously reported a position in MRK as recently as Q2 2023.

Highview Capital Management first reported a position in MRK in Q4 2021 and has held it in 8 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Highview Capital Management held 11,128 shares of Merck worth $1.62M as of Q3 2026.
  • Merck was a new Highview Capital Management position in Q3 2026.
  • Merck made up 0.46% of Highview Capital Management's portfolio in Q3 2026, its #58 holding.
  • Highview Capital Management first reported a position in Merck in Q4 2021 and has held it in 8 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Highview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.